Year-over-year earnings per share growth for the last twelve months: inmedpharma.com (INM)

inmedpharma.com - graphic logo of issuer INM

The stability of the North American market minimizes risks for InMed Pharmaceuticals (INM), yet quarterly EPS dynamics exhibit volatility, with the latest figure standing at 2.50. Logistics disruptions for active substances and sanctions limit expansion, but success in the development of rare cannabinoids and a biosynthetic IT platform restore confidence, creating potential for future merger and acquisition deals.

inmedpharma.com (INM) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/09/2026

Comprehensive metric breakdowns and analytics for InMed (INM)

- share price and expert price forecast:
Stock Price InMed Pharmaceuticals Inc.|INM - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value InMed Pharma|INM - Business Value
- book capitalization data:
Net Assets per Single Share InMed Pharmaceuticals|INM - Company Net Assets|Market Capitalization to Book Value Ratio inmedpharma.com|INM - Company Assets
- debt and solvency information:
Total Debt to Capital InMed Pharmaceuticals|INM - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio InMed Pharmaceuticals|INM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio InMed Pharma|INM - Long-Term Liabilities|Company Short-Term Debts InMed Pharmaceuticals|Quick Ratio inmedpharma.com
- earnings and market multiples details:
INM - Net Profit|Expected Profit InMed Pharmaceuticals|INM - Company Value to Net Income|Future Price to Earnings InMed Pharma|INM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple InMed Pharma|INM - Operating profit EBITDA|Net earnings per share (EPS TTM) InMed Pharmaceuticals|INM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth inmedpharma.com|INM - Earnings per share growth rate in current year|Expected earnings per share growth for next year InMed Pharmaceuticals
- revenue and sales proceeds data:
INM - Revenue and Sales Volume|Company Future Sales Volume InMed Pharmaceuticals Inc.|INM - Market Cap to Sales Volume|Forward P/S Multiple InMed Pharma
Summary company analytics:InMed Pharmaceuticals
Flagship merchandise of inmedpharma.com

The efficiency of the secured distribution of orphan drugs by InMed Pharmaceuticals (INM) directly impacts net income, reflecting a trend of quarterly EPS growth. This metric measures earnings per share dynamics, revealing supply and demand imbalances prior to official reports; its steady ascent confirms the operational resilience of the business, while sharp declines signal fundamental risks to the asset.

Competing companies

INDV: Quarterly EPS earnings growth|COLL - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cronos|Year-over-year earnings per share growth for the last 12 months CGC (Canopy Growth Corp.)|Year-over-year earnings per share growth for the last twelve months High Tide Inc. (HITI)|Year-over-year net earnings per share growth for the last 12 months auroramj.com ACB|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc.)|skyebioscience.com (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo - Quarterly EPS earnings growth|INCR (InterCure Ltd.) - Year-over-year earnings per share growth for the last 12 months|NTRB (nutriband.com) - Year-over-year net earnings per share growth for the last 12 months|Nasus Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months India Globalization Capital|MIRA Pharma - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth FLGC|IMCC (imcannabis.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ADIL (Adial Pharmaceuticals, Inc.)|Quarterly EPS earnings growth Artelo Biosciences Inc. ARTL|ENSC - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months TTNP (Titan Pharmaceuticals)|Greenlane Holdings Inc (GNLN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Akanda Inc|ENVB (Enveric Biosciences) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Bright Green Corp|Quarterly EPS earnings growth HPCO